Real-World Performance of Abbott’s SyncAV CRT Technology @ HRS2021 

Dr. Mohit K. Chawla presents on the real-world performance of Abbott’s
SyncAV CRT Technology at HRS 2021. Looking at SyncAV technology,
patient outcomes, mortality, morbitity, readmissions and cost analysis and
benefit of SyncAV technology.
This video is intended for healthcare professionals.
To view important safety information for Gallant and Entrant CRT-Ds visit:
www.cardiovasc...
cardiac-resynchronization-therapy/gallant/indications-safetywarnings.
html
www.cardiovasc...
cardiac-resynchronization-therapy/entrant/indications-safetywarnings.
html
Introduction 0:00
SyncAV CRT Technology 1:04
Real World Outcomes and Data 8:08
Conclusion 12:51
Case Report 13:30
MAT-2113087 v1.0 | Item approved for U.S. use